See more : SEPC Limited (SHRIRAMEPC.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Rossari Biotech Limited (ROSSARI.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rossari Biotech Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Sintex Plastics Technology Limited (SPTL.NS) Income Statement Analysis – Financial Results
- JD.com, Inc. (013A.F) Income Statement Analysis – Financial Results
- Amuse Inc. (4301.T) Income Statement Analysis – Financial Results
- Discovery Alaska Limited (DRVYF) Income Statement Analysis – Financial Results
- Altisource Asset Management Corporation (AAMC) Income Statement Analysis – Financial Results
Rossari Biotech Limited (ROSSARI.BO)
About Rossari Biotech Limited
Rossari Biotech Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it provides poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. The company was founded in 1997 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.31B | 16.56B | 14.83B | 7.07B | 5.98B | 5.13B | 2.91B | 2.35B |
| Cost of Revenue | 15.14B | 11.71B | 11.08B | 4.65B | 3.81B | 3.48B | 2.02B | 1.96B |
| Gross Profit | 3.17B | 4.85B | 3.75B | 2.42B | 2.17B | 1.66B | 899.21M | 385.70M |
| Gross Profit Ratio | 17.31% | 29.26% | 25.30% | 34.26% | 36.29% | 32.26% | 30.85% | 16.42% |
| Research & Development | 70.17M | 82.55M | 50.27M | 75.01M | 53.53M | 38.62M | 31.39M | 47.10M |
| General & Administrative | 169.73M | 153.35M | 151.16M | 84.24M | 57.10M | 35.15M | 32.37M | 0.00 |
| Selling & Marketing | 643.56M | 666.69M | 511.21M | 347.37M | 407.93M | 342.20M | 93.94M | 0.00 |
| SG&A | 813.29M | 1.16B | 662.37M | 431.61M | 465.03M | 377.35M | 126.31M | 141.22M |
| Other Expenses | 0.00 | 54.84M | 119.96M | 17.00M | 700.00K | 590.00K | 640.00K | 0.00 |
| Operating Expenses | 1.17B | 3.24B | 2.40B | 1.42B | 1.29B | 999.20M | 523.53M | 188.32M |
| Cost & Expenses | 16.44B | 14.96B | 13.48B | 6.07B | 5.10B | 4.47B | 2.54B | 2.15B |
| Interest Income | 22.39M | 25.21M | 40.67M | 42.65M | 15.44M | 6.55M | 5.06M | 1.61M |
| Interest Expense | 193.72M | 223.15M | 126.56M | 29.92M | 35.57M | 28.78M | 13.55M | 21.31M |
| Depreciation & Amortization | 603.90M | 629.31M | 480.55M | 228.29M | 168.52M | 121.87M | 51.73M | 43.45M |
| EBITDA | 2.57B | 2.12B | 1.94B | 1.31B | 1.08B | 784.57M | 440.02M | 238.61M |
| EBITDA Ratio | 14.05% | 13.86% | 13.28% | 18.37% | 18.13% | 15.36% | 15.11% | 10.25% |
| Operating Income | 1.83B | 1.55B | 1.32B | 1.02B | 891.82M | 658.21M | 377.34M | 197.38M |
| Operating Income Ratio | 9.98% | 9.36% | 8.90% | 14.35% | 14.91% | 12.83% | 12.95% | 8.40% |
| Total Other Income/Expenses | -51.03M | -2.23B | -1.55B | 53.05M | -13.41M | -22.45M | -940.00K | -10.27M |
| Income Before Tax | 1.78B | 1.44B | 1.36B | 1.07B | 878.41M | 633.92M | 374.74M | 187.11M |
| Income Before Tax Ratio | 9.70% | 8.71% | 9.19% | 15.10% | 14.68% | 12.35% | 12.86% | 7.97% |
| Income Tax Expense | 469.26M | 369.62M | 385.80M | 267.92M | 225.88M | 177.09M | 120.71M | 44.26M |
| Net Income | 1.31B | 1.07B | 976.74M | 802.20M | 652.53M | 456.83M | 254.03M | 142.85M |
| Net Income Ratio | 7.14% | 6.48% | 6.59% | 11.34% | 10.91% | 8.90% | 8.72% | 6.08% |
| EPS | 23.67 | 19.46 | 17.81 | 15.58 | 13.42 | 9.44 | 5.25 | 6.49 |
| EPS Diluted | 23.62 | 19.38 | 17.70 | 15.49 | 13.23 | 9.44 | 5.25 | 6.49 |
| Weighted Avg Shares Out | 55.21M | 55.11M | 54.85M | 51.57M | 48.62M | 48.40M | 48.40M | 22.00M |
| Weighted Avg Shares Out (Dil) | 55.33M | 55.36M | 55.17M | 51.87M | 49.32M | 48.40M | 48.40M | 22.00M |
Source: https://incomestatements.info
Category: Stock Reports